Blood-Brain Barrier Dysfunction Linked to Major Psychiatric Disorders in New Review
A new comparative review, involving researchers from Ben-Gurion University of the Negev, Israel, has found evidence linking blood-brain barrier (BBB) dysfunction to major psychiatric disorders, including major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia. The review analyzed 261 publications, primarily from 2000 to 2026, with 80% published since 2020. The blood-brain barrier typically regulates the passage of substances from the blood into the brain. When this barrier weakens, inflammatory molecules, immune cells, and other potentially harmful substances can gain increased access to brain tissue. The review highlights inflammation, oxidative stress, mitochondrial dysfunction, metabolic abnormalities, and disrupted stress-hormone signaling as interconnected processes that can damage the BBB. In MDD, human imaging studies show increased BBB permeability in the prefrontal cortex and hippocampus, with postmortem findings indicating reduced claudin-5 and occludin proteins. For bipolar dis...